A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40-Reference-Cited by-同舟云学术

A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

Published:2015-04-14 Issue:1 Volume:8 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Chen Jingtao,Zurawski Gerard,Zurawski Sandy,Wang Zhiqing,Akagawa Keiko,Oh Sangkon,Hideki Ueno,Fay Joseph,Banchereau Jacques,Song Wenru,Palucka A Karolina

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-015-0131-7.pdf

Reference56 articles.

1. Foran JM, Cunningham D, Coiffier B, Solal-Celigny P, Reyes F, Ghielmini M, et al. Treatment of mantle-cell lymphoma with rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Ann Oncol. 2000;11 Suppl 1:117–21.

2. Chen Y, Wang M, Romaguera J. Current regimens and novel agents for mantle cell lymphoma. Br J Haematol. 2014.

3. Dreyling, M., et al. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma (MCL) - summary of the 12 annual conference of the EUROPEAN MCL NETWORK. Leuk Lymphoma, 2014. p. 1–26.

4. Williams ME, Dreyling MH, Kahl BS, Leonard JP, O'Connor OA, Press OW, et al. Mantle cell lymphoma: report of the 2009 mantle cell lymphoma consortium workshop. Leuk Lymphoma. 2010;51(3):390–8.

5. Dietrich S et al. Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol. 2014;25(5):1053–8.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation CD40 agonists for cancer immunotherapy;Expert Opinion on Biological Therapy;2024-05-03

2. A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease;Cell Reports Medicine;2024-03

3. STxB as an Antigen Delivery Tool for Mucosal Vaccination;Toxins;2022-03-10

4. Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy;OncoImmunology;2021-01-01

5. Atypical cyclins in cancer: New kids on the block?;Seminars in Cell & Developmental Biology;2020-11